ProfileGDS4177 / 214231_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 66% 65% 76% 81% 76% 77% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated73.6666
GSM603099KU-812 non-treated69.5865
GSM603098KCL-22 Imatinib-treated157.7776
GSM603097KCL-22 non-treated247.3881
GSM603102JURL-MK1 Imatinib-treated148.5976
GSM603101JURL-MK1 non-treated162.0877